Latest Market Access News

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Nagambie Resources reported significant new antimony-gold intersections at its Nagambie Mine and joined a US Department of Defence consortium, positioning itself amid soaring antimony prices and strategic demand. The company also advanced funding arrangements and plans a resource update in the June quarter.

Wide Open Agriculture has inked an exclusive 18-month distribution agreement with Univar Solutions China to market its lupin protein products, marking a strategic push into the lucrative Chinese plant-based protein sector.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

Energy Metals Limited has reported a 12% increase in uranium resources at its flagship Bigrlyi Joint Venture, strengthening its position amid a stable uranium market and robust cash reserves. The company is advancing exploration plans across its Northern Territory and Western Australia projects for 2025.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Volt Resources Limited reports strong quarterly progress in graphite production and downstream development, securing new orders and partnerships while advancing US refinery plans and implementing cost-saving measures.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Syrah Resources halts production at its Balama graphite mine amid ongoing protests while advancing its US-based Vidalia anode material facility, securing a significant $165 million US tax credit and forging key offtake deals.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.